カテゴリ： 世界, 医療/バイオ, QYResearch

軟骨保護剤の世界市場2023年：ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩

■ 英語タイトル：Global Chondroprotective Agent Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8722）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8722
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[軟骨保護剤の世界市場2023年：ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は軟骨保護剤のグローバル市場について調査・分析し、世界の軟骨保護剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩）、用途別セグメント分析（病院、外来手術センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SANXIN、WanTuMing Biological、TSI Group、Yantai Dongcheng、Focus Chem、YBCC、Runxin Biotechnology、ISBA、Huiwen、QJBCHINA、Meitek (Synutra International)、Hengjie Bio-Pharmaceuticals、Nippon Zoki、GGI、Summit Nutritionals、Sioux Pharm、Ruikangda Biochemical、Guanglong Biochem、Pacific Rainbowなどが含まれています。軟骨保護剤のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、軟骨保護剤市場規模を算出する際に考慮しました。

・軟骨保護剤市場の概要
- 製品の定義
- 軟骨保護剤の種類別セグメント
- 世界の軟骨保護剤市場規模：タイプ別分析（ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩）
- 軟骨保護剤の用途別セグメント
- 世界の軟骨保護剤市場規模：用途別分析（病院、外来手術センター）
- 世界の軟骨保護剤市場規模予測（2018年-2029年）
- 軟骨保護剤の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 軟骨保護剤市場の競争状況およびトレンド

・軟骨保護剤の地域別市場規模
- 北米の軟骨保護剤市場規模（2018年-2029年）
- 米国の軟骨保護剤市場規模（2018年-2029年）
- ヨーロッパの軟骨保護剤市場規模（2018年-2029年）
- アジア太平洋の軟骨保護剤市場規模（2018年-2029年）
- 中国の軟骨保護剤市場規模（2018年-2029年）
- 日本の軟骨保護剤市場規模（2018年-2029年）
- 韓国の軟骨保護剤市場規模（2018年-2029年）
- インドの軟骨保護剤市場規模（2018年-2029年）
- オーストラリアの軟骨保護剤市場規模（2018年-2029年）
- 中南米の軟骨保護剤市場規模（2018年-2029年）
- 中東・アフリカの軟骨保護剤市場規模（2018年-2029年）

・種類別セグメント：ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩
- 世界の軟骨保護剤のタイプ別販売量（2018年-2023年）
- 世界の軟骨保護剤のタイプ別売上（2018年-2023年）
- 世界の軟骨保護剤のタイプ別価格

・用途別セグメント：病院、外来手術センター
- 世界の軟骨保護剤の用途別販売量（2018年-2023年）
- 世界の軟骨保護剤の用途別売上（2018年-2023年）
- 世界の軟骨保護剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
SANXIN、WanTuMing Biological、TSI Group、Yantai Dongcheng、Focus Chem、YBCC、Runxin Biotechnology、ISBA、Huiwen、QJBCHINA、Meitek (Synutra International)、Hengjie Bio-Pharmaceuticals、Nippon Zoki、GGI、Summit Nutritionals、Sioux Pharm、Ruikangda Biochemical、Guanglong Biochem、Pacific Rainbow

・産業チェーンと販売チャネルの分析
- 軟骨保護剤産業チェーン分析
- 軟骨保護剤の主要原材料
- 軟骨保護剤の販売チャネル
- 軟骨保護剤のディストリビューター
- 軟骨保護剤の主要顧客

・軟骨保護剤市場ダイナミクス
- 軟骨保護剤の業界動向
- 軟骨保護剤市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Chondroprotective Agent market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Chondroprotective Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Chondroprotective Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Chondroprotective Agent include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chondroprotective Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chondroprotective Agent.
The Chondroprotective Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chondroprotective Agent market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chondroprotective Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow
Segment by Type
Sodium Hyaluronate
Glucosamine Sulfate
Chondroitin Sulfate
Segment by Application
Hospital
Ambulatory Surgery Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chondroprotective Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chondroprotective Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Chondroprotective Agent Market Overview
1.1 Product Overview and Scope of Chondroprotective Agent
1.2 Chondroprotective Agent Segment by Type
1.2.1 Global Chondroprotective Agent Market Value Comparison by Type (2023-2029)
1.2.2 Sodium Hyaluronate
1.2.3 Glucosamine Sulfate
1.2.4 Chondroitin Sulfate
1.3 Chondroprotective Agent Segment by Application
1.3.1 Global Chondroprotective Agent Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Global Chondroprotective Agent Market Size Estimates and Forecasts
1.4.1 Global Chondroprotective Agent Revenue 2018-2029
1.4.2 Global Chondroprotective Agent Sales 2018-2029
1.4.3 Global Chondroprotective Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Chondroprotective Agent Market Competition by Manufacturers
2.1 Global Chondroprotective Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Chondroprotective Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Chondroprotective Agent Average Price by Manufacturers (2018-2023)
2.4 Global Chondroprotective Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Chondroprotective Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chondroprotective Agent, Product Type & Application
2.7 Chondroprotective Agent Market Competitive Situation and Trends
2.7.1 Chondroprotective Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chondroprotective Agent Players Market Share by Revenue
2.7.3 Global Chondroprotective Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chondroprotective Agent Retrospective Market Scenario by Region
3.1 Global Chondroprotective Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Chondroprotective Agent Global Chondroprotective Agent Sales by Region: 2018-2029
3.2.1 Global Chondroprotective Agent Sales by Region: 2018-2023
3.2.2 Global Chondroprotective Agent Sales by Region: 2024-2029
3.3 Global Chondroprotective Agent Global Chondroprotective Agent Revenue by Region: 2018-2029
3.3.1 Global Chondroprotective Agent Revenue by Region: 2018-2023
3.3.2 Global Chondroprotective Agent Revenue by Region: 2024-2029
3.4 North America Chondroprotective Agent Market Facts & Figures by Country
3.4.1 North America Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Chondroprotective Agent Sales by Country (2018-2029)
3.4.3 North America Chondroprotective Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chondroprotective Agent Market Facts & Figures by Country
3.5.1 Europe Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Chondroprotective Agent Sales by Country (2018-2029)
3.5.3 Europe Chondroprotective Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chondroprotective Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Chondroprotective Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Chondroprotective Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chondroprotective Agent Market Facts & Figures by Country
3.7.1 Latin America Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Chondroprotective Agent Sales by Country (2018-2029)
3.7.3 Latin America Chondroprotective Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chondroprotective Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Chondroprotective Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Chondroprotective Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chondroprotective Agent Sales by Type (2018-2029)
4.1.1 Global Chondroprotective Agent Sales by Type (2018-2023)
4.1.2 Global Chondroprotective Agent Sales by Type (2024-2029)
4.1.3 Global Chondroprotective Agent Sales Market Share by Type (2018-2029)
4.2 Global Chondroprotective Agent Revenue by Type (2018-2029)
4.2.1 Global Chondroprotective Agent Revenue by Type (2018-2023)
4.2.2 Global Chondroprotective Agent Revenue by Type (2024-2029)
4.2.3 Global Chondroprotective Agent Revenue Market Share by Type (2018-2029)
4.3 Global Chondroprotective Agent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Chondroprotective Agent Sales by Application (2018-2029)
5.1.1 Global Chondroprotective Agent Sales by Application (2018-2023)
5.1.2 Global Chondroprotective Agent Sales by Application (2024-2029)
5.1.3 Global Chondroprotective Agent Sales Market Share by Application (2018-2029)
5.2 Global Chondroprotective Agent Revenue by Application (2018-2029)
5.2.1 Global Chondroprotective Agent Revenue by Application (2018-2023)
5.2.2 Global Chondroprotective Agent Revenue by Application (2024-2029)
5.2.3 Global Chondroprotective Agent Revenue Market Share by Application (2018-2029)
5.3 Global Chondroprotective Agent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SANXIN
6.1.1 SANXIN Corporation Information
6.1.2 SANXIN Description and Business Overview
6.1.3 SANXIN Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SANXIN Chondroprotective Agent Product Portfolio
6.1.5 SANXIN Recent Developments/Updates
6.2 WanTuMing Biological
6.2.1 WanTuMing Biological Corporation Information
6.2.2 WanTuMing Biological Description and Business Overview
6.2.3 WanTuMing Biological Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 WanTuMing Biological Chondroprotective Agent Product Portfolio
6.2.5 WanTuMing Biological Recent Developments/Updates
6.3 TSI Group
6.3.1 TSI Group Corporation Information
6.3.2 TSI Group Description and Business Overview
6.3.3 TSI Group Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TSI Group Chondroprotective Agent Product Portfolio
6.3.5 TSI Group Recent Developments/Updates
6.4 Yantai Dongcheng
6.4.1 Yantai Dongcheng Corporation Information
6.4.2 Yantai Dongcheng Description and Business Overview
6.4.3 Yantai Dongcheng Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yantai Dongcheng Chondroprotective Agent Product Portfolio
6.4.5 Yantai Dongcheng Recent Developments/Updates
6.5 Focus Chem
6.5.1 Focus Chem Corporation Information
6.5.2 Focus Chem Description and Business Overview
6.5.3 Focus Chem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Focus Chem Chondroprotective Agent Product Portfolio
6.5.5 Focus Chem Recent Developments/Updates
6.6 YBCC
6.6.1 YBCC Corporation Information
6.6.2 YBCC Description and Business Overview
6.6.3 YBCC Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 YBCC Chondroprotective Agent Product Portfolio
6.6.5 YBCC Recent Developments/Updates
6.7 Runxin Biotechnology
6.6.1 Runxin Biotechnology Corporation Information
6.6.2 Runxin Biotechnology Description and Business Overview
6.6.3 Runxin Biotechnology Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Runxin Biotechnology Chondroprotective Agent Product Portfolio
6.7.5 Runxin Biotechnology Recent Developments/Updates
6.8 ISBA
6.8.1 ISBA Corporation Information
6.8.2 ISBA Description and Business Overview
6.8.3 ISBA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ISBA Chondroprotective Agent Product Portfolio
6.8.5 ISBA Recent Developments/Updates
6.9 Huiwen
6.9.1 Huiwen Corporation Information
6.9.2 Huiwen Description and Business Overview
6.9.3 Huiwen Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huiwen Chondroprotective Agent Product Portfolio
6.9.5 Huiwen Recent Developments/Updates
6.10 QJBCHINA
6.10.1 QJBCHINA Corporation Information
6.10.2 QJBCHINA Description and Business Overview
6.10.3 QJBCHINA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 QJBCHINA Chondroprotective Agent Product Portfolio
6.10.5 QJBCHINA Recent Developments/Updates
6.11 Meitek (Synutra International)
6.11.1 Meitek (Synutra International) Corporation Information
6.11.2 Meitek (Synutra International) Chondroprotective Agent Description and Business Overview
6.11.3 Meitek (Synutra International) Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Meitek (Synutra International) Chondroprotective Agent Product Portfolio
6.11.5 Meitek (Synutra International) Recent Developments/Updates
6.12 Hengjie Bio-Pharmaceuticals
6.12.1 Hengjie Bio-Pharmaceuticals Corporation Information
6.12.2 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Description and Business Overview
6.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product Portfolio
6.12.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
6.13 Nippon Zoki
6.13.1 Nippon Zoki Corporation Information
6.13.2 Nippon Zoki Chondroprotective Agent Description and Business Overview
6.13.3 Nippon Zoki Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nippon Zoki Chondroprotective Agent Product Portfolio
6.13.5 Nippon Zoki Recent Developments/Updates
6.14 GGI
6.14.1 GGI Corporation Information
6.14.2 GGI Chondroprotective Agent Description and Business Overview
6.14.3 GGI Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 GGI Chondroprotective Agent Product Portfolio
6.14.5 GGI Recent Developments/Updates
6.15 Summit Nutritionals
6.15.1 Summit Nutritionals Corporation Information
6.15.2 Summit Nutritionals Chondroprotective Agent Description and Business Overview
6.15.3 Summit Nutritionals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Summit Nutritionals Chondroprotective Agent Product Portfolio
6.15.5 Summit Nutritionals Recent Developments/Updates
6.16 Sioux Pharm
6.16.1 Sioux Pharm Corporation Information
6.16.2 Sioux Pharm Chondroprotective Agent Description and Business Overview
6.16.3 Sioux Pharm Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sioux Pharm Chondroprotective Agent Product Portfolio
6.16.5 Sioux Pharm Recent Developments/Updates
6.17 Ruikangda Biochemical
6.17.1 Ruikangda Biochemical Corporation Information
6.17.2 Ruikangda Biochemical Chondroprotective Agent Description and Business Overview
6.17.3 Ruikangda Biochemical Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ruikangda Biochemical Chondroprotective Agent Product Portfolio
6.17.5 Ruikangda Biochemical Recent Developments/Updates
6.18 Guanglong Biochem
6.18.1 Guanglong Biochem Corporation Information
6.18.2 Guanglong Biochem Chondroprotective Agent Description and Business Overview
6.18.3 Guanglong Biochem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Guanglong Biochem Chondroprotective Agent Product Portfolio
6.18.5 Guanglong Biochem Recent Developments/Updates
6.19 Pacific Rainbow
6.19.1 Pacific Rainbow Corporation Information
6.19.2 Pacific Rainbow Chondroprotective Agent Description and Business Overview
6.19.3 Pacific Rainbow Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Pacific Rainbow Chondroprotective Agent Product Portfolio
6.19.5 Pacific Rainbow Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chondroprotective Agent Industry Chain Analysis
7.2 Chondroprotective Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chondroprotective Agent Production Mode & Process
7.4 Chondroprotective Agent Sales and Marketing
7.4.1 Chondroprotective Agent Sales Channels
7.4.2 Chondroprotective Agent Distributors
7.5 Chondroprotective Agent Customers
8 Chondroprotective Agent Market Dynamics
8.1 Chondroprotective Agent Industry Trends
8.2 Chondroprotective Agent Market Drivers
8.3 Chondroprotective Agent Market Challenges
8.4 Chondroprotective Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Chondroprotective Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Chondroprotective Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Chondroprotective Agent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Chondroprotective Agent Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Chondroprotective Agent Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Chondroprotective Agent Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Chondroprotective Agent Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Chondroprotective Agent Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Chondroprotective Agent, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Chondroprotective Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chondroprotective Agent, Product Type & Application
Table 12. Global Key Manufacturers of Chondroprotective Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chondroprotective Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chondroprotective Agent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chondroprotective Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Chondroprotective Agent Sales by Region (2018-2023) & (K Units)
Table 18. Global Chondroprotective Agent Sales Market Share by Region (2018-2023)
Table 19. Global Chondroprotective Agent Sales by Region (2024-2029) & (K Units)
Table 20. Global Chondroprotective Agent Sales Market Share by Region (2024-2029)
Table 21. Global Chondroprotective Agent Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Chondroprotective Agent Revenue Market Share by Region (2018-2023)
Table 23. Global Chondroprotective Agent Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Chondroprotective Agent Revenue Market Share by Region (2024-2029)
Table 25. North America Chondroprotective Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Chondroprotective Agent Sales by Country (2018-2023) & (K Units)
Table 27. North America Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 28. North America Chondroprotective Agent Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Chondroprotective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Chondroprotective Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Chondroprotective Agent Sales by Country (2018-2023) & (K Units)
Table 32. Europe Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 33. Europe Chondroprotective Agent Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Chondroprotective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Chondroprotective Agent Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Chondroprotective Agent Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Chondroprotective Agent Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Chondroprotective Agent Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Chondroprotective Agent Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Chondroprotective Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Chondroprotective Agent Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Chondroprotective Agent Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Chondroprotective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Chondroprotective Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Chondroprotective Agent Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Chondroprotective Agent Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Chondroprotective Agent Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Chondroprotective Agent Sales (K Units) by Type (2018-2023)
Table 51. Global Chondroprotective Agent Sales (K Units) by Type (2024-2029)
Table 52. Global Chondroprotective Agent Sales Market Share by Type (2018-2023)
Table 53. Global Chondroprotective Agent Sales Market Share by Type (2024-2029)
Table 54. Global Chondroprotective Agent Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Chondroprotective Agent Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Chondroprotective Agent Revenue Market Share by Type (2018-2023)
Table 57. Global Chondroprotective Agent Revenue Market Share by Type (2024-2029)
Table 58. Global Chondroprotective Agent Price (US$/Unit) by Type (2018-2023)
Table 59. Global Chondroprotective Agent Price (US$/Unit) by Type (2024-2029)
Table 60. Global Chondroprotective Agent Sales (K Units) by Application (2018-2023)
Table 61. Global Chondroprotective Agent Sales (K Units) by Application (2024-2029)
Table 62. Global Chondroprotective Agent Sales Market Share by Application (2018-2023)
Table 63. Global Chondroprotective Agent Sales Market Share by Application (2024-2029)
Table 64. Global Chondroprotective Agent Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Chondroprotective Agent Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Chondroprotective Agent Revenue Market Share by Application (2018-2023)
Table 67. Global Chondroprotective Agent Revenue Market Share by Application (2024-2029)
Table 68. Global Chondroprotective Agent Price (US$/Unit) by Application (2018-2023)
Table 69. Global Chondroprotective Agent Price (US$/Unit) by Application (2024-2029)
Table 70. SANXIN Corporation Information
Table 71. SANXIN Description and Business Overview
Table 72. SANXIN Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. SANXIN Chondroprotective Agent Product
Table 74. SANXIN Recent Developments/Updates
Table 75. WanTuMing Biological Corporation Information
Table 76. WanTuMing Biological Description and Business Overview
Table 77. WanTuMing Biological Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. WanTuMing Biological Chondroprotective Agent Product
Table 79. WanTuMing Biological Recent Developments/Updates
Table 80. TSI Group Corporation Information
Table 81. TSI Group Description and Business Overview
Table 82. TSI Group Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. TSI Group Chondroprotective Agent Product
Table 84. TSI Group Recent Developments/Updates
Table 85. Yantai Dongcheng Corporation Information
Table 86. Yantai Dongcheng Description and Business Overview
Table 87. Yantai Dongcheng Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Yantai Dongcheng Chondroprotective Agent Product
Table 89. Yantai Dongcheng Recent Developments/Updates
Table 90. Focus Chem Corporation Information
Table 91. Focus Chem Description and Business Overview
Table 92. Focus Chem Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Focus Chem Chondroprotective Agent Product
Table 94. Focus Chem Recent Developments/Updates
Table 95. YBCC Corporation Information
Table 96. YBCC Description and Business Overview
Table 97. YBCC Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. YBCC Chondroprotective Agent Product
Table 99. YBCC Recent Developments/Updates
Table 100. Runxin Biotechnology Corporation Information
Table 101. Runxin Biotechnology Description and Business Overview
Table 102. Runxin Biotechnology Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Runxin Biotechnology Chondroprotective Agent Product
Table 104. Runxin Biotechnology Recent Developments/Updates
Table 105. ISBA Corporation Information
Table 106. ISBA Description and Business Overview
Table 107. ISBA Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ISBA Chondroprotective Agent Product
Table 109. ISBA Recent Developments/Updates
Table 110. Huiwen Corporation Information
Table 111. Huiwen Description and Business Overview
Table 112. Huiwen Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Huiwen Chondroprotective Agent Product
Table 114. Huiwen Recent Developments/Updates
Table 115. QJBCHINA Corporation Information
Table 116. QJBCHINA Description and Business Overview
Table 117. QJBCHINA Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. QJBCHINA Chondroprotective Agent Product
Table 119. QJBCHINA Recent Developments/Updates
Table 120. Meitek (Synutra International) Corporation Information
Table 121. Meitek (Synutra International) Description and Business Overview
Table 122. Meitek (Synutra International) Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Meitek (Synutra International) Chondroprotective Agent Product
Table 124. Meitek (Synutra International) Recent Developments/Updates
Table 125. Hengjie Bio-Pharmaceuticals Corporation Information
Table 126. Hengjie Bio-Pharmaceuticals Description and Business Overview
Table 127. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product
Table 129. Hengjie Bio-Pharmaceuticals Recent Developments/Updates
Table 130. Nippon Zoki Corporation Information
Table 131. Nippon Zoki Description and Business Overview
Table 132. Nippon Zoki Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Nippon Zoki Chondroprotective Agent Product
Table 134. Nippon Zoki Recent Developments/Updates
Table 135. GGI Corporation Information
Table 136. GGI Description and Business Overview
Table 137. GGI Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. GGI Chondroprotective Agent Product
Table 139. GGI Recent Developments/Updates
Table 140. Summit Nutritionals Corporation Information
Table 141. Summit Nutritionals Description and Business Overview
Table 142. Summit Nutritionals Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Summit Nutritionals Chondroprotective Agent Product
Table 144. Summit Nutritionals Recent Developments/Updates
Table 145. Sioux Pharm Corporation Information
Table 146. Sioux Pharm Description and Business Overview
Table 147. Sioux Pharm Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Sioux Pharm Chondroprotective Agent Product
Table 149. Sioux Pharm Recent Developments/Updates
Table 150. Ruikangda Biochemical Corporation Information
Table 151. Ruikangda Biochemical Description and Business Overview
Table 152. Ruikangda Biochemical Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Ruikangda Biochemical Chondroprotective Agent Product
Table 154. Ruikangda Biochemical Recent Developments/Updates
Table 155. Guanglong Biochem Corporation Information
Table 156. Guanglong Biochem Description and Business Overview
Table 157. Guanglong Biochem Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Guanglong Biochem Chondroprotective Agent Product
Table 159. Guanglong Biochem Recent Developments/Updates
Table 160. Pacific Rainbow Corporation Information
Table 161. Pacific Rainbow Description and Business Overview
Table 162. Pacific Rainbow Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Pacific Rainbow Chondroprotective Agent Product
Table 164. Pacific Rainbow Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Chondroprotective Agent Distributors List
Table 168. Chondroprotective Agent Customers List
Table 169. Chondroprotective Agent Market Trends
Table 170. Chondroprotective Agent Market Drivers
Table 171. Chondroprotective Agent Market Challenges
Table 172. Chondroprotective Agent Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chondroprotective Agent
Figure 2. Global Chondroprotective Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Chondroprotective Agent Market Share by Type in 2022 & 2029
Figure 4. Sodium Hyaluronate Product Picture
Figure 5. Glucosamine Sulfate Product Picture
Figure 6. Chondroitin Sulfate Product Picture
Figure 7. Global Chondroprotective Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Chondroprotective Agent Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Ambulatory Surgery Center
Figure 11. Global Chondroprotective Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Chondroprotective Agent Market Size (2018-2029) & (US$ Million)
Figure 13. Global Chondroprotective Agent Sales (2018-2029) & (K Units)
Figure 14. Global Chondroprotective Agent Average Price (US$/Unit) & (2018-2029)
Figure 15. Chondroprotective Agent Report Years Considered
Figure 16. Chondroprotective Agent Sales Share by Manufacturers in 2022
Figure 17. Global Chondroprotective Agent Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Chondroprotective Agent Players: Market Share by Revenue in 2022
Figure 19. Chondroprotective Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Chondroprotective Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Chondroprotective Agent Sales Market Share by Country (2018-2029)
Figure 22. North America Chondroprotective Agent Revenue Market Share by Country (2018-2029)
Figure 23. United States Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Chondroprotective Agent Sales Market Share by Country (2018-2029)
Figure 26. Europe Chondroprotective Agent Revenue Market Share by Country (2018-2029)
Figure 27. Germany Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Chondroprotective Agent Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Chondroprotective Agent Revenue Market Share by Region (2018-2029)
Figure 34. China Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Chondroprotective Agent Sales Market Share by Country (2018-2029)
Figure 44. Latin America Chondroprotective Agent Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Chondroprotective Agent Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Chondroprotective Agent Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Chondroprotective Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Chondroprotective Agent by Type (2018-2029)
Figure 54. Global Revenue Market Share of Chondroprotective Agent by Type (2018-2029)
Figure 55. Global Chondroprotective Agent Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Chondroprotective Agent by Application (2018-2029)
Figure 57. Global Revenue Market Share of Chondroprotective Agent by Application (2018-2029)
Figure 58. Global Chondroprotective Agent Price (US$/Unit) by Application (2018-2029)
Figure 59. Chondroprotective Agent Value Chain
Figure 60. Chondroprotective Agent Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 粘膜下注入剤の世界市場2023年：シリンジ式、アンプル式
  • レベリング剤の世界市場2023年：ポリエステルレベリング剤、ポリアミドレベリング剤、セルロースレベリング剤、ウールレベリング剤、その他
  • 脂肪族アミン硬化剤の世界市場2023年：エチレンジアミン、ヘキサンジアミン、ジエチレントリアミン、トリエチレンテトラミン、テトラエチレンペンタミン
  • 農薬分散剤の世界市場2023年：アニオン系農薬分散剤、カチオン系農薬分散剤
  • 防カビ剤の世界市場2023年：合成、天然
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8722 )"軟骨保護剤の世界市場2023年：ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩" (英文：Global Chondroprotective Agent Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。